Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overweight or Obese Participants”

315 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 315 results

Early research (Phase 1)Study completedNCT06567327
What this trial is testing

Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese

Who this might be right for
Obesity
Pfizer 82
Early research (Phase 1)Study completedNCT05814107
What this trial is testing

Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 DiabetesOverweight or Obesity
Carmot Australia First Pty Ltd 94
Early research (Phase 1)Looking for participantsNCT07465965
What this trial is testing

A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults

Who this might be right for
OverweightObesity
Shanghai World Leader Pharmaceutical Co., Ltd. 60
Large-scale testing (Phase 3)Study completedNCT05929066
What this trial is testing

Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight

Who this might be right for
ObesityOverweightOsteoarthritis, Knee+1 more
Eli Lilly and Company 2,335
Early research (Phase 1)Not Yet RecruitingNCT07815067
What this trial is testing

A Research Study Looking at the Effect of Timing of Meal After Dosing and Water Volume at Dosing on How the Medicine Zenagamtide is Taken up by the Body of Participants With Overweight or Obesity

Who this might be right for
OverweightObesity
Novo Nordisk A/S 320
Large-scale testing (Phase 3)Looking for participantsNCT07743463
What this trial is testing

Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Who this might be right for
ObesityOverweightChronic Weight Management
Ascletis Pharma (China) Co., Limited 3,003
Large-scale testing (Phase 3)Looking for participantsNCT07226765
What this trial is testing

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy

Who this might be right for
Obstructive Sleep Apnea
Amgen 250
Testing effectiveness (Phase 2)Study completedNCT06867718
What this trial is testing

Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions

Who this might be right for
Obesity or Overweight
Regor Pharmaceuticals Inc. 267
Early research (Phase 1)Looking for participantsNCT07511205
What this trial is testing

Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity.

Who this might be right for
Healthy ParticipantsObesity
AstraZeneca 104
Large-scale testing (Phase 3)Study completedNCT04184622
What this trial is testing

Tirzepatide (LY3298176) in Participants With Obesity or Overweight

Who this might be right for
OverweightObesity
Eli Lilly and Company 2,539
Early research (Phase 1)Looking for participantsNCT07673900
What this trial is testing

Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants

Who this might be right for
Overweight and/or Obesity
Terrestrial Bio, Inc. 62
Large-scale testing (Phase 3)Looking for participantsNCT07776509
What this trial is testing

Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Who this might be right for
Obesity or OverweightWeight-Related ComorbidityWith/Without Diabetes Mellitus, Type 2
AstraZeneca 500
Early research (Phase 1)Study completedNCT07414784
What this trial is testing

ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives

Who this might be right for
Healthy Volunteer
AbbVie 20
Testing effectiveness (Phase 2)Looking for participantsNCT07441252
What this trial is testing

A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight

Who this might be right for
Overweight or Obesity and Elevated Liver Fat
Amgen 180
Large-scale testing (Phase 3)Active Not RecruitingNCT07232719
What this trial is testing

Retatrutide (LY3437943) in Participants With Obesity or Overweight

Who this might be right for
ObesityOverweight
Eli Lilly and Company 250
Early research (Phase 1)Study completedNCT07226778
What this trial is testing

Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous (SC) Presentations

Who this might be right for
OverweightObesity
Amgen 348
Large-scale testing (Phase 3)Study completedNCT06309992
What this trial is testing

Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)

Who this might be right for
ObesityNon-Alcoholic SteatoHepatitis (NASH)
Boehringer Ingelheim 218
Large-scale testing (Phase 3)Active Not RecruitingNCT07104500
What this trial is testing

VK2735 for Weight Management Phase 3

Who this might be right for
Weight Loss
Viking Therapeutics, Inc. 4,500
Large-scale testing (Phase 3)Looking for participantsNCT07284901
What this trial is testing

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Who this might be right for
Obesity With DiabetesOverweight With Diabetes
Kailera 1,156
Testing effectiveness (Phase 2)Looking for participantsNCT07589608
What this trial is testing

Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Who this might be right for
OverweightObesity
Eli Lilly and Company 400
Next Page